Primary outcome reduced by anti-inflammatory drug in chronic coronary disease
Educational information
This video was recorded during the virtual congress of the ESC 2020.
Faculty
Mark Nidorf, MD - cardiologist, Perth, Australia
Disclosures
The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.
Share this page with your colleagues and friends: